Cellular composition in the lungs at 5 weeks after infection
. | Cells positive 5 weeks after infection, % . | . | |
---|---|---|---|
Cell type . | WT . | TMpro/pro . | |
CD4+ | 48.4 ± 4.2 | 47.8 ± 2.2 | |
CD8+ | 37.3 ± 2.4 | 34.3 ± 2.1 | |
CD4+/CD69+ | 15.1 ± 1.2 | 17.8 ± 2.0 | |
CD4+/CD25+ | 2.3 ± 1.3 | 4.1 ± 2.1 | |
CD8+/CD69+ | 12.9 ± 6.2 | 10.1 ± 3.2 | |
CD8+/CD25+ | 4.9 ± 1.3 | 3.6 ± 1.4 | |
Gr-1+/CD11b+ | 22.9 ± 2.1 | 19.5 ± 1.8 |
. | Cells positive 5 weeks after infection, % . | . | |
---|---|---|---|
Cell type . | WT . | TMpro/pro . | |
CD4+ | 48.4 ± 4.2 | 47.8 ± 2.2 | |
CD8+ | 37.3 ± 2.4 | 34.3 ± 2.1 | |
CD4+/CD69+ | 15.1 ± 1.2 | 17.8 ± 2.0 | |
CD4+/CD25+ | 2.3 ± 1.3 | 4.1 ± 2.1 | |
CD8+/CD69+ | 12.9 ± 6.2 | 10.1 ± 3.2 | |
CD8+/CD25+ | 4.9 ± 1.3 | 3.6 ± 1.4 | |
Gr-1+/CD11b+ | 22.9 ± 2.1 | 19.5 ± 1.8 |
Lymphocyte typing was performed on pulmonary cell suspensions 5 weeks after infection as described in “FACS analysis.” Data are mean ± SE of 8 mice per group. FACS results of the lymphocytes are expressed as the percentage of CD4+, CD8+, CD25+, and CD69+ population; results of neutrophils as percentage CD11b+ cells within the Gr-1+ population. Differences between groups were not significant.